More than 100 stakeholder groups call on US Congress leadership to reauthorize PAHPA
Center News
November 14, 2023 – Today, more than 100 stakeholders, including the Johns Hopkins Center for Health Security, Biotechnology Innovation Organization (BIO), Association of State and Territorial Health Officials (ASTHO), and other groups representing academia, industry, and research institutes, sent a letter to congressional leadership urging them to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) before the end of the calendar year and with the same bipartisan support it has had since its original authorization 17 years ago.
Led by the Johns Hopkins Center for Health Security, the coalition called on Senate Majority Leader Charles Schumer, Senate Minority Leader Mitch McConnell, House Speaker Mike Johnson, and House Minority Leader Hakeem Jeffries to include a comprehensive 5-year PAHPA reauthorization in moving legislation this year.
“Our nation’s changing health security threat landscape and the federal government’s responsibility to protect the American people demand that we work together now to find a strong bipartisan path forward to reauthorize this critical legislation,” write the signatories. “Failing to reauthorize PAHPA would have serious effects on our country’s economic well-being, national security, and health security given the rapidly changing threat landscape.”
Read the full letter.
Read the updated letter from January 16, 2024, with additional signatories.
Read the updated letter from March 1, 2024, with additional signatories.
Signatories, in alphabetical order:
- 1Day Sooner
- 3M*
- Acadian Ambulance Service, Inc.
- Adaptive Phage Therapeutics
- Adjuvant Capital, L.P.^
- AdvaMed*
- Aequor Inc.
- Air National Guard^
- Alliance for Biosecurity*
- Altor Safety*
- America’s Essential Hospitals
- American Academy of Pediatrics^
- American Ambulance Association
- American Association of Neurological Surgeons*
- American Clinical Laboratory Association*
- American College of Emergency Physicians
- American College of Surgeons
- American Hospital Association
- American Lung Association
- American Medical Manufacturers Association (AMMA)*
- American Medical Women’s Association^
- American Pharmacies
- American Public Health Association
- American Society for Microbiology
- American Society of Anesthesiologists^
- Antheia, Inc.^
- Arizona Bioindustry Association, Inc. (AZBio)
- Association for Professionals in Infection Control and Epidemiology
- Association of American Medical Colleges*
- Association of Maternal & Child Health Programs
- Association of Public Health Laboratories*
- Association of State and Territorial Health Officials
- Asthma and Allergy Foundation of America
- AstraZeneca Pharmaceuticals
- ATCC
- Atea Pharmaceuticals, Inc.
- Bavarian Nordic
- Belfer Center of Science and International Affairs^
- Big Cities Health Coalition
- Biocom California*
- BioCT
- BioForward Wisconsin
- BioKansas
- BioNJ
- Biotechnology Innovation Organization (BIO)
- Blu Zone Bioscience^
- Bugworks
- Cencora
- Civitas Networks for Health*
- Codagenix^
- Colorado BioScience Association
- CommonSpirit Health*
- Congress of Neurological Surgeons*
- Council of State and Territorial Epidemiologists
- Council of State Bioscience Associations (CSBA)
- CSL Seqirus
- Emergency Department Practice Management Association
- Emergent BioSolutions
- FAH*
- Federation of American Scientists
- FluGen Inc.
- George Washington University Disaster Medicine^
- Georgetown University^
- Georgia Bio
- Gerontological Society of America
- Ginkgo Bioworks
- Global Health Investment Corporation
- Global Health Technologies Coalition
- Gryphon Scientific
- GSK
- Hamilton Grace LLC^
- Health Industry Distributors Association (HIDA)
- Healthcare Distribution Alliance
- Healthcare Leadership Council
- Healthcare Ready
- Healthtrek Healthcare LLP^
- Helix
- HIMSS
- HIV Medicine Association
- IAVI
- Illinois Biotechnology Innovation Organization
- Indiana Health Industry Forum*
- InDevR Inc.^
- Infectious Diseases Society of America
- INOVIO Pharmaceuticals
- Institute for Progress
- Johns Hopkins Center for Health Security
- Jurata Thin Film, Inc^
- Life Sciences PA
- Locus Biosciences
- Lutema USA^
- Mallinckrodt
- Marked By Covid
- Mass General Brigham*
- MassBio
- McKesson
- Medical Alley
- Medical Countermeasures Coalition
- Missouri Biotechnology Association (MOBIO)
- Monod Bio, Inc.^
- Morehouse School of Medicine - Atlanta, GA*
- Mount Sinai Health System*
- National Association of County and City Health Officials
- National Immigration Law Center
- NC Life Sciences Organization*
- Neuroene Therapeutics^
- New Mexico Biotechnoiogy & Biomedical Association (NMBio)
- New Orleans BioInnovation Center
- NewYorkBIO
- NexGen Parks^
- NightHawk Biosciences
- Novavax
- Ochsner Health
- Ohio Life Sciences Association
- Oklahoma Bioscience Association
- PDS Biotechnology
- PharmaJet Inc.
- Premier Inc.
- Public Health Accreditation Board
- READDI Inc.*
- Research!America
- RS BioTherapeutics, Inc.^
- SAB Biotherapeutics, Inc.
- Safe Health Systems^
- Sanofi
- SecureBio
- Shionogi Inc.
- SIGA Technologies, Inc.
- Society for Public Health Education
- Soligenix, Inc.
- Technologies for Pandemic Defense
- Texas A&M Health Science Center*
- Texas Healthcare & Bioscience Institute
- Tonix Pharmaceuticals
- Trauma Anesthesiology Society^
- Trinity Health
- TrippBio, Inc.
- True North BioPharm, LLC^
- Trust for America’s Health
- United Safety Technology Inc*
- United States Pharmacopeia (USP)
- University of Colorado^
- University of Hawaii
- University of Maryland School of Medicine
- University of Nebraska System^
- Valneva USA
- Vaxess Technologies*
- Vaxxas Inc
- Virginia Biotechnology Association
- Washington State University*
* Denotes signatures added on January 16, 2024.
^ Denotes signatures added on March 1, 2024.